STDs (sexually transmitted diseases), also referred to as STIs (sexually transmitted infections), are infections that are primarily spread through sexual contact. The agents of these diseases can include bacteria, viruses, and parasites. Common examples of STDs include chlamydia, gonorrhea, genital herpes, HIV/AIDS, and human papillomavirus (HPV). STDs can present a range of symptoms, including but not limited to genital sores, itching, discharge, and pain during urination; however, many individuals may be asymptomatic, which can increase the risk of unknowingly transmitting the infection to others.
New research[1] launched at the 29th EADV Congress, EADV Virtual, has found that despite the COVID-19 (SARS-CoV-2) lockdown restrictions, diagnosis of sexually transmitted infections (STIs),…
A novel noninvasive technique may detect human papilloma virus-16, the strain associated with oropharyngeal cancer, in saliva samples, reports The Journal of Molecular Diagnostics. Unfortunately,…
A school-based human papillomavirus (HPV) immunization program in British Columbia, Canada, is dramatically reducing rates of cervical pre-cancer in B.C. women, according to a new…
The HPV vaccine is one of only two vaccines that prevent cancer but is underutilized in the United States. Despite its proven success in preventing…
Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day. In a…
Biologists at Columbia University Vagelos College of Physicians and Surgeons have leveraged a computational method to map protein-protein interactions between all known human-infecting viruses and…
Scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs. Artificial human organs, or…
A team of researchers has found HIV-1 broadly neutralizing antibody precursor B cells that are present in most people, and has described the design of…
New research from Yale University shows that novel antiviral therapies for hepatitis C could reduce the prevalence of the blood-borne infection by more than 80%….
A new study from the Yale School of Medicine found that nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval…
New research from Yale University shows that the use of protease inhibitor-based antiretroviral therapy for HIV is an effective measure for reducing malaria in HIV-infected…
New research from Yale University reveals that cell-to-cell transmission of HIV particles contributes to the development of full-blown AIDS and helps predict which anti-retroviral therapies…
(This article has been translated into English) An international team of researchers has designed small synthetic molecules capable of binding to the genetic material of…
By turning HIV against itself, researchers at the Queensland Institute of Medical Research have demonstrated the ability to stop HIV replication in a laboratory environment….
A new vaccine trial has revealed a weak spot in HIV, which could lead to an effective vaccine against AIDS. The vaccine turns the immune…
Researchers have discovered a vaccine, developed from a single strain, that has shown to be effective against all known strains of hepatitis C. Further research…
Dr. Chil-Yong Kang and his team at The University of Western Ontario have been studying HIV for the last twenty years and working on a…
Dr. Samuel French and his team of researchers at UCLA’s Jonsson Comprehensive Cancer Center have continued to build on previous research that identified two cellular…